Free Trial

Allspring Global Investments Holdings LLC Has $81.95 Million Stake in HealthEquity, Inc. $HQY

HealthEquity logo with Medical background

Key Points

  • Allspring Global Investments Holdings LLC has reduced its stake in HealthEquity, Inc. by 10%, now owning 796,472 shares valued at approximately $81.95 million.
  • Several institutional investors have increased their holdings in HealthEquity, with notable increases including a 232.4% stake rise by Farther Finance Advisors LLC and a 1,366% increase by Larson Financial Group LLC.
  • HealthEquity reported a quarterly EPS of $0.92, meeting analysts' consensus estimates, and has guided for FY 2026 EPS between $3.740 - $3.91.
  • Interested in HealthEquity? Here are five stocks we like better.

Allspring Global Investments Holdings LLC lowered its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 10.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 796,472 shares of the company's stock after selling 88,358 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.92% of HealthEquity worth $81,949,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Farther Finance Advisors LLC increased its stake in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company's stock valued at $26,000 after purchasing an additional 172 shares in the last quarter. WPG Advisers LLC acquired a new stake in shares of HealthEquity in the 1st quarter valued at about $28,000. Northwestern Mutual Wealth Management Co. increased its position in HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock valued at $58,000 after buying an additional 418 shares in the last quarter. Sellwood Investment Partners LLC acquired a new position in HealthEquity during the 2nd quarter worth approximately $58,000. Finally, Larson Financial Group LLC boosted its holdings in HealthEquity by 1,366.0% in the first quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after acquiring an additional 642 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the company's stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of HealthEquity stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the sale, the executive vice president owned 79,456 shares in the company, valued at $7,477,604.16. The trade was a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.50% of the company's stock.

HealthEquity Stock Performance

Shares of HQY stock opened at $93.23 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The firm has a 50-day moving average of $91.66 and a 200-day moving average of $93.95. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company has a market cap of $8.03 billion, a P/E ratio of 56.50, a P/E/G ratio of 1.30 and a beta of 0.47.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Barrington Research restated an "outperform" rating and set a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Weiss Ratings restated a "hold (c+)" rating on shares of HealthEquity in a research note on Wednesday, October 8th. JPMorgan Chase & Co. raised their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research note on Wednesday, September 3rd. Royal Bank Of Canada boosted their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, September 3rd. Finally, Jefferies Financial Group upped their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a "buy" rating in a report on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $121.31.

Read Our Latest Report on HQY

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.